Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria

  • 1, 2Email author,
  • 3,
  • 4,
  • 5,
  • 6 and
  • 7
BMC Clinical Pharmacology201212:14

https://doi.org/10.1186/1472-6904-12-14

  • Received: 18 June 2012
  • Accepted: 21 June 2012
  • Published:

The original article was published in BMC Clinical Pharmacology 2012 12:7

Correction

After publication of the article it was noted that we inadvertently failed to include the complete list of authors. The full list, including co-authors, has now been added and the Authors' contributions section modified accordingly.

Notes

Declarations

Authors’ Affiliations

(1)
Department of Operations Research, HIV/AIDS Program. Population Council, Nigeria. No. 16, Mafemi Crescent, Utako, Abuja, Nigeria
(2)
Department of Health Policy and Management, Diadem Consults Ltd, Abuja, Nigeria
(3)
Management Sciences for Health, Abuja, Nigeria
(4)
Howard University PACE Center, Washington, USA
(5)
Society for Family Health, Abuja, Nigeria
(6)
Family Health International 360, Pretoria, South Africa
(7)
UNDP Regional Center for Europe and Central Asia, Bratislavia, Slovakia

References

  1. Eluwa GI, Badru T, Agu KA: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin Pharm. 2012, 12: 7-10.1186/1472-6904-12-7.View ArticleGoogle Scholar
  2. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6904/12/14/prepub

Copyright

Advertisement